Literature DB >> 26864244

An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference.

Ariel Alonso1, Wim Van der Elst2, Geert Molenberghs3,2, Marc Buyse2,4, Tomasz Burzykowski2,4.   

Abstract

In this work a new metric of surrogacy, the so-called individual causal association (ICA), is introduced using information-theoretic concepts and a causal inference model for a binary surrogate and true endpoint. The ICA has a simple and appealing interpretation in terms of uncertainty reduction and, in some scenarios, it seems to provide a more coherent assessment of the validity of a surrogate than existing measures. The identifiability issues are tackled using a two-step procedure. In the first step, the region of the parametric space of the distribution of the potential outcomes, compatible with the data at hand, is geometrically characterized. Further, in a second step, a Monte Carlo approach is proposed to study the behavior of the ICA on the previous region. The method is illustrated using data from the Collaborative Initial Glaucoma Treatment Study. A newly developed and user-friendly R package Surrogate is provided to carry out the evaluation exercise.
© 2016, The International Biometric Society.

Entities:  

Keywords:  Causal inference; Information theory; Monte Carlo; Surrogate endpoints

Mesh:

Substances:

Year:  2016        PMID: 26864244     DOI: 10.1111/biom.12483

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  4 in total

1.  Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial.

Authors:  Paul Meyvisch; Chrispin Kambili; Koen Andries; Nacer Lounis; Myriam Theeuwes; Brian Dannemann; An Vandebosch; Wim Van der Elst; Geert Molenberghs; Ariel Alonso
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

2.  Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol.

Authors:  Anthony Muchai Manyara; Philippa Davies; Derek Stewart; Valerie Wells; Christopher Weir; Amber Young; Rod Taylor; Oriana Ciani
Journal:  BMJ Open       Date:  2022-10-13       Impact factor: 3.006

3.  Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.

Authors:  Anthony Muchai Manyara; Philippa Davies; Derek Stewart; Christopher J Weir; Amber Young; Nancy J Butcher; Sylwia Bujkiewicz; An-Wen Chan; Gary S Collins; Dalia Dawoud; Martin Offringa; Mario Ouwens; Joseph S Ross; Rod S Taylor; Oriana Ciani
Journal:  BMJ Open       Date:  2022-10-11       Impact factor: 3.006

Review 4.  Lessons learned from IDeAl - 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials.

Authors:  Ralf-Dieter Hilgers; Malgorzata Bogdan; Carl-Fredrik Burman; Holger Dette; Mats Karlsson; Franz König; Christoph Male; France Mentré; Geert Molenberghs; Stephen Senn
Journal:  Orphanet J Rare Dis       Date:  2018-05-11       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.